Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07847489Phase 1Completed
Phase 1, randomised trial of dexamethasone and magnesium sulfate (3 arms), sponsored by Ain Shams University. Primary endpoints: Time to onset of accepted akinesia score at 6 months and Need of supplemental injection at 6 months. Started May 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07847489.